December 11, 2014

The Food and Drug Administration on Wednesday approved Gardasil 9 for the prevention of certain diseases caused by nine types of human papillomavirus.

October 10, 2014

The Food and Drug Administration on Friday approved Akynzeo (netupitant and palonosetron) for the treatment of nausea and vomiting in patients who are undergoing cancer chemotherapy.

October 7, 2014

America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.

 

October 7, 2014

Walmart on Tuesday announced it is expanding its Centers of Excellence program.

October 3, 2014

Kroger on Thursday kicked off its annual #SharingCourage campaign, asking customers to join in the fight against breast cancer by taking action online and in local communities.

October 1, 2014

Stand Up To Cancer, the Safeway Foundation and actress and comedienne Wanda Sykes on Tuesday collaborated on a campaign to raise money and public awareness for breast cancer and treatment.

September 29, 2014

Cardinal Health Specialty Solutions and KEW Group agree to make KEW's diagnostic services available to Specialty Solutions' community oncology customers.

September 26, 2014

As part of its new Women’s Wellness initiative, Schnucks Pharmacies has announced that four different oral breast cancer medications (Letrozole, Megestrol, Anastrozole and Tamoxifen) will be available for $9 with a valid prescription.

September 17, 2014

The Skin Cancer Foundation’s annual Road to Healthy Skin Tour, presented by Rite Aid, recently wrapped up its seventh cross-country journey, providing free skin cancer screenings and prevention information to communities nationwide.

July 30, 2014

Susan G. Komen honored Walgreens at its annual Susan G. Komen Leadership Conference, held July 17-19 here, with its Mission Possible Award.

July 24, 2014

Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.

July 23, 2014

The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.

July 17, 2014

Women know that dairy, whole grains, fruits and vegetables are keys to a balanced diet – yet many aren't eating them because of the uncomfortable consequences that often occur when they do.

July 7, 2014

In honor of Breast Cancer Awareness Month, Psi Bands on Monday formed a charitable partnership with the National Breast Cancer Foundation, which provides help to those affected by breast cancer through early detection, education and support services.

June 30, 2014

AccentHealth on Thursday announced it has entered into a strategic relationship with the American Cancer Society.

May 27, 2014

For the seventh consecutive year, Rite Aid will serve as the presenting sponsor of the Skin Cancer Foundation’s annual Road to Healthy Skin Tour beginning Tuesday.

May 7, 2014

The pace of annual global spending on oncology medicines — which is approaching the $100 billion threshold — has moderated over the past five years, even as a surge in innovative and targeted therapies has brought new therapeutic options to the growing number of patients being treated for cancer and as survival rates for most tumor types continue to increase, according to a new report released Tuesday by the IMS Institute for Healthcare Informatics.

April 24, 2014

The Food and Drug Administration on Thursday approved a human papillomavirus DNA test for women 25 years of age and older that can be used to help health care professionals assess the need for a woman to undergo additional testing for cervical cancer.

April 23, 2014

Specialty pharmacy operator Diplomat has access to dispense Arzerra, a cancer treatment with a recently expanded indication, the company noted Tuesday.

April 21, 2014

GlaxoSmithKline and Genmab A/S announced last week that the Food and Drug Administration has approved a supplemental biologic license application for the use of Arzerra (ofatumumab) in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia for whom fludarabine-based therapy is considered inappropriate.

February 13, 2014

Janssen Biotech announced that the Food and Drug Administration has approved Imbruvica (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy.

January 28, 2014

Hygenic/Performance Health, maker of Perform Pain Reliever, on Tuesday announced that the company had increased in-store activity with an Instant Redeemable Coupon program in support of Pink-Link Breast Cancer Support Network, an online support resource for women affected by breast cancer.

January 20, 2014

The Food and Drug Administration recently approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (i.e., cannot be removed by surgery) or metastatic (i.e., late-stage), Onco360 announced last week.

January 15, 2014

Drug maker AbbVie has started a late-stage clinical trial of an experimental drug for treating triple-negative breast cancer, the company said Wednesday.